BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Shi YH, Shi CH. Molecular characteristics and stages of chronic hepatitis B virus infection. World J Gastroenterol 2009; 15(25): 3099-3105 [PMID: 19575488 DOI: 10.3748/wjg.15.3099]
URL: https://www.wjgnet.com/1007-9327/full/v15/i25/3099.htm
Number Citing Articles
1
Chenggang Shi, Jiyi Huang, Xun Liu, Xiaolin Zeng, Cailian Cheng, Qiongli Yin, Mei Li, Guifeng Cheng. Diagnostic significance of hepatitis B viral antigens in patients with glomerulonephritis-associated hepatitis B virus infectionDiagnostic Microbiology and Infectious Disease 2012; 72(2): 156 doi: 10.1016/j.diagmicrobio.2011.11.003
2
Paul Martin, Daryl T.-Y. Lau, Mindie H. Nguyen, Harry L.A. Janssen, Douglas T. Dieterich, Marion G. Peters, Ira M. Jacobson. A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 UpdateClinical Gastroenterology and Hepatology 2015; 13(12): 2071 doi: 10.1016/j.cgh.2015.07.007
3
Özge Gümüşay, Seren Özenirler, Ayşegül Atak, Cemile Sönmez, Seçil Özkan, Ayşe Fıtnat Tuncel, Güldal Yılmaz, Gülen Akyol. Diagnostic potential of serum direct markers and non-invasive fibrosis models in patients with chronic hepatitis BHepatology Research 2013; 43(3): 228 doi: 10.1111/j.1872-034X.2012.01057.x
4
Simon Peter Kayondo, Josaphat K Byamugisha, Peter Ntuyo. Prevalence of hepatitis B virus infection and associated risk factors among pregnant women attending antenatal clinic in Mulago Hospital, Uganda: a cross-sectional studyBMJ Open 2020; 10(6): e033043 doi: 10.1136/bmjopen-2019-033043
5
Arvin Medhat, Alla Arzumanyan, Mark A. Feitelson. Hepatitis B x antigen (HBx) is an important therapeutic target in the pathogenesis of hepatocellular carcinomaOncotarget 2021;  doi: 10.18632/oncotarget.28077
6
Danielle Alves Gomes Zauli, Carla Lisandre Paula de Menezes, Cristiane Lommez de Oliveira, Elvis Cristian Cueva Mateo, Alessandro Clayton de Souza Ferreira. In-house quantitative real-time PCR for the diagnosis of hepatitis B virus and hepatitis C virus infectionsBrazilian Journal of Microbiology 2016; 47(4): 987 doi: 10.1016/j.bjm.2016.07.008
7
Irina P Balmasova, Nikolay D Yushchuk, Ospan A Mynbaev, Nageswara R Alla, Elena S Malova, Zhongjie Shi, Chang-Lu Gao. Immunopathogenesis of chronic hepatitis BWorld Journal of Gastroenterology 2014; 20(39): 14156-14171 doi: 10.3748/wjg.v20.i39.14156
8
Jingui Bao, Yu Lu, Yan Deng, Chengzhi Rong, Yanqiong Liu, Xiuli Huang, Liuying Song, Shan Li, Xue Qin. Association between IL-18 polymorphisms, serum levels, and HBV-related hepatocellular carcinoma in a Chinese population: a retrospective case–control studyCancer Cell International 2015; 15(1) doi: 10.1186/s12935-015-0223-z
9
Georgia Zeng, Upkar S Gill, Patrick T F Kennedy. Prioritisation and the initiation of HCC surveillance in CHB patients: lessons to learn from the COVID-19 crisisGut 2020; 69(11): 1907 doi: 10.1136/gutjnl-2020-321627
10
Ying-Hui Shi. Correlation between Hepatitis B Virus Genotypes and Clinical OutcomesJapanese Journal of Infectious Diseases 2012; 65(6): 476 doi: 10.7883/yoken.65.476
11
Young Min Park. Clinical utility of complex mutations in the core promoter and proximal precore regions of the hepatitis B virus genomeWorld Journal of Hepatology 2015; 7(1): 113-120 doi: 10.4254/wjh.v7.i1.113
12
Ersan Ozaslan, Tugrul Purnak. Controversies about occult hepatitis B virus infectionWorld Journal of Gastroenterology 2009; 15(39): 4986-4987 doi: 10.3748/wjg.15.4986
13
Luisa Barboza, Siham Salmen, Guillermo Teran-Angel, Darrell L. Peterson, Lisbeth Berrueta. A deficient translocation of CD3ζ, ZAP-70 and Grb2 to lipid raft, as a hallmark of defective adaptive immune response during chronic hepatitis B infectionCellular Immunology 2013; 284(1-2): 9 doi: 10.1016/j.cellimm.2013.05.008
14
Anusha Vittal, Marc G. Ghany. WHO Guidelines for Prevention, Care and Treatment of Individuals Infected with HBVClinics in Liver Disease 2019; 23(3): 417 doi: 10.1016/j.cld.2019.04.008
15
Xiaolei Jiao, Ying Luo, Bin Yang, Li Jing, Yayue Li, Changzheng Liu, Xiang Jing, Fengmei Wang, Yijun Wang, Zhi Du, Yingtang Gao. The MTHFR C677T mutation is not a risk factor recognized for HBV-related HCC in a population with a high prevalence of this genetic markerInfection, Genetics and Evolution 2017; 49: 66 doi: 10.1016/j.meegid.2017.01.008
16
Marta Bes, Victor Vargas, Maria Piron, Natalia Casamitjana, Juan Ignacio Esteban, Nuria Vilanova, Asuncion Pinacho, Josep Quer, Lluis Puig, Jaime Guardia, Silvia Sauleda. T cell responses and viral variability in blood donation candidates with occult hepatitis B infectionJournal of Hepatology 2012; 56(4): 765 doi: 10.1016/j.jhep.2011.11.011
17
R.K. Mondal, M. Khatun, S. Ghosh, P. Banerjee, S. Datta, S. Sarkar, B. Saha, A. Santra, S. Banerjee, A. Chowdhury, S. Datta. Immune-driven adaptation of hepatitis B virus genotype D involves preferential alteration in B-cell epitopes and replicative attenuation—an insight from human immunodeficiency virus/hepatitis B virus coinfectionClinical Microbiology and Infection 2015; 21(7): 710.e11 doi: 10.1016/j.cmi.2015.03.004
18
Onur Gokce, Seren Ozenirler, Aysegul Atak Yucel, Nihan Oruklu, Guldal Yilmaz Esendagli, Sevilay Karahan. Evaluation of serum procollagen C-proteinase enhancer 1 level as a fibrosis marker in patients with chronic hepatitis BEuropean Journal of Gastroenterology & Hepatology 2018; 30(8): 918 doi: 10.1097/MEG.0000000000001123
19
Young Min Park, Seong Gyu Lee. Clinical features of HBsAg seroclearance in hepatitis B virus carriers in South Korea: A retrospective longitudinal studyWorld Journal of Gastroenterology 2016; 22(44): 9836-9843 doi: 10.3748/wjg.v22.i44.9836
20
Rebecca T. Horvat. Clinical Virology Manual2016; : 341 doi: 10.1128/9781555819156.ch24
21
Hui Nie, Alison A. Evans, W. Thomas London, Timothy M. Block, Xiangdong David Ren. Quantitative dynamics of hepatitis B basal core promoter and precore mutants before and after HBeAg seroconversionJournal of Hepatology 2012; 56(4): 795 doi: 10.1016/j.jhep.2011.11.012
22
S. Boumbaly, E. N. Serikova, A. V. Semenov, Yu. V. Ostankova, D. E. Valutite, A. N. Schemelev, E. B. Zueva, T. A.L. Balde, R. R. Baimova, A. A. Totolian. Significance of parenteral viral hepatitis laboratory diagnostics in the Republic of GuineaJournal of microbiology, epidemiology and immunobiology 2021; 98(4): 440 doi: 10.36233/0372-9311-116
23
Louise Rodrigues, Natalia Freitas, Bhaskar V. Kallakury, Stephan Menne, Severin O. Gudima, G. McFadden. Superinfection with Woodchuck Hepatitis Virus Strain WHVNY of Livers Chronically Infected with Strain WHV7Journal of Virology 2015; 89(1): 384 doi: 10.1128/JVI.02361-14
24
Sohair K. Sayed, Mohammad A. kobeisy. The relationship between core promoter mutation of hepatitis B virus, viral load and hepatitis B e antigen status in chronic hepatitis B patientsCellular Immunology 2012; 276(1-2): 35 doi: 10.1016/j.cellimm.2012.03.003
25
Koffi Alain Attia, Ya Henriette Kissi, Stanislas Doffou, Demba Bangoura, Roseline Flora Wilson, Georges Bougha, Fulgence Yao Bathaix, Kouame Alassan Mahassadi, Mohamed Sayegh, Therese N’dri-Yoman. Prevalence of hepatitis B infection and factors associated in children of Ivorian HBsAg carrier subjectsOpen Journal of Gastroenterology 2013; 3(04): 237 doi: 10.4236/ojgas.2013.34040
26
C. Gauder, L.N. Mojsiejczuk, L. Tadey, L. Mammana, M.B. Bouzas, R.H. Campos, D.M. Flichman. Role of viral load in Hepatitis B virus evolution in persistently normal ALT chronically infected patientsInfection, Genetics and Evolution 2019; 67: 17 doi: 10.1016/j.meegid.2018.10.017
27
Bernd Koeberlein, Axel zur Hausen, Nuran Bektas, Hanswalter Zentgraf, Ruth Chin, Nguyen Linh Toan, Reinhard Kandolf, Joseph Torresi, C.- Thomas Bock. Hepatitis B virus overexpresses suppressor of cytokine signaling-3 (SOCS3) thereby contributing to severity of inflammation in the liverVirus Research 2010; 148(1-2): 51 doi: 10.1016/j.virusres.2009.12.003
28
Man Li, Zhen-Hua Zhou, Xue-Hua Sun, Xin Zhang, Xiao-Jun Zhu, Shu-Gen Jin, Ya-Ting Gao, Yun Jiang, Yue-Qiu Gao. Hepatitis B core antigen upregulates B7-H1 on dendritic cells by activating the AKT/ERK/P38 pathway: a possible mechanism of hepatitis B virus persistenceLaboratory Investigation 2016; 96(11): 1156 doi: 10.1038/labinvest.2016.96
29
Tianju Wang, Chunmei Shen, Liping Chen, Sheng Liu, Yanhong Ji. Association of human leukocyte antigen polymorphisms with occult hepatitis B virus infection in a Shaanxi Han populationThe Journal of Gene Medicine 2017; 19(9-10): e2987 doi: 10.1002/jgm.2987
30
Yong Jin Jung, Jin-Wook Kim, Soo Jin Park, Bo Young Min, Eun Sun Jang, Nam Young Kim, Sook-Hyang Jeong, Cheol Min Shin, Sang Hyub Lee, Young Soo Park, Jin-Hyeok Hwang, Nayoung Kim, Dong Ho Lee. c-Myc-mediated overexpression of miR-17-92 suppresses replication of hepatitis B virus in human hepatoma cellsJournal of Medical Virology 2013; 85(6): 969 doi: 10.1002/jmv.23534
31
John R. Brill. Sexually Transmitted Infections in MenPrimary Care: Clinics in Office Practice 2010; 37(3): 509 doi: 10.1016/j.pop.2010.04.003
32
Ban M. Al-Kanaan, Mushtak T.S. Al-Ouqaili, Khalid F.A. Al-Rawi. Detection of cytokines (IL-1α and IL-2) and oxidative stress markers in hepatitis B envelope antigen-positive and -negative chronic hepatitis B patients: Molecular and biochemical studyGene Reports 2019; 17: 100504 doi: 10.1016/j.genrep.2019.100504
33
György Berencsi, Márta Csire. Maternal Fetal Transmission of Human Viruses and their Influence on Tumorigenesis2012; : 105 doi: 10.1007/978-94-007-4216-1_4
34
Parham Safaie, Mugilan Poongkunran, Ping-Ping Kuang, Asad Javaid, Carl Jacobs, Rebecca Pohlmann, Imad Nasser, Daryl TY Lau. Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinomaWorld Journal of Gastroenterology 2016; 22(12): 3404-3411 doi: 10.3748/wjg.v22.i12.3404
35
Yu Lu, Jie Zeng, Shi Yang, Zuojian Hu, Limin Li, Hongli Yu, Xue Qin. Association between the rs9131 and rs3806792 polymorphisms of the CXCL2 gene and the risk of HBV‐related hepatocellular carcinoma in a Guangxi populationJournal of Clinical Laboratory Analysis 2020; 34(8) doi: 10.1002/jcla.23310
36
Ferruccio Bonino, Maurizia Rossana Brunetto. Occult Hepatitis B Virus (HBV) Infections: Hepatitis B Surface Antigen (HBsAg) Negative and Primary OccultCurrent Hepatitis Reports 2013; 12(2): 112 doi: 10.1007/s11901-013-0164-8
37
Dramane Kania, Laure Ottomani, Nicolas Meda, Marianne Peries, Pierre Dujols, Karine Bolloré, Wendy Rénier, Johannes Viljoen, Jacques Ducos, Philippe Van de Perre, Edouard Tuaillon. Performance of two real-time PCR assays for hepatitis B virus DNA detection and quantitationJournal of Virological Methods 2014; 201: 24 doi: 10.1016/j.jviromet.2014.01.015
38
Man Li, Zhen-Hua Zhou, Xue-Hua Sun, Xin Zhang, Xiao-Jun Zhu, Shu-Gen Jin, Yun Jiang, Ya-Ting Gao, Cheng-Zhong Li, Yue-Qiu Gao. The dynamic changes of circulating invariant natural killer T cells during chronic hepatitis B virus infectionHepatology International 2016; 10(4): 594 doi: 10.1007/s12072-015-9650-0
39
Mona Abdel-Hady, Deirdre Kelly. Chronic Hepatitis B in Children and Adolescents: Epidemiology and ManagementPediatric Drugs 2013; 15(4): 311 doi: 10.1007/s40272-013-0010-z
40
Neil D. Theise, Henry C. Bodenheimer, Linda D. Ferrell. MacSween's Pathology of the Liver2012; : 361 doi: 10.1016/B978-0-7020-3398-8.00007-6
41
Man Li, Xue-Hua Sun, Xiao-Jun Zhu, Shu-Gen Jin, Zhen-Jun Zeng, Zhen-Hua Zhou, Zhuo Yu, Yue-Qiu Gao. HBcAg induces PD-1 upregulation on CD4+T cells through activation of JNK, ERK and PI3K/AKT pathways in chronic hepatitis-B-infected patientsLaboratory Investigation 2012; 92(2): 295 doi: 10.1038/labinvest.2011.157
42
Amr Abdelkader Fateen, Rasha Youssef Shahin, Mohamed Nazmy Farres, Mai Ahmed Eldeeb, Hanaa Ahmed Amer. Assessment of hepatic fibrosis and necroinflammation among inactive HBsAg carriers in EgyptAnnals of Hepatology 2012; 11(4): 464 doi: 10.1016/S1665-2681(19)31459-0
43
Christos Liaskos, Athanasios Mavropoulos, Timoklia Orfanidou, Vassiliki Spyrou, Labrini V. Athanasiou, Charalambos Billinis. The immunopathogenetic role of autoantibodies in canine autoimmune hepatitis: lessons to learn from human autoimmune hepatitisAutoimmunity Highlights 2012; 3(3): 87 doi: 10.1007/s13317-012-0036-1
44
Agnieszka Lawrenczyk, Seil Kim, Xiangshu Wen, Ran Xiong, Weiming Yuan. Exploring the Therapeutic Potentials of iNKT Cells for Anti-HBV TreatmentPathogens 2014; 3(3): 563 doi: 10.3390/pathogens3030563
45
Chia-Hsuin Chang, Jou-Wei Lin, Yu-Kang Tu. Secular trends were considered in the evaluation of universal hepatitis B vaccination in TaiwanJournal of Clinical Epidemiology 2015; 68(4): 405 doi: 10.1016/j.jclinepi.2014.11.014
46
Xinying Zhao, Xudong Guo, Libo Xing, Wenqin Yue, Haisen Yin, Miaoxia He, Jianmin Wang, Jianmin Yang, Jie Chen. HBV infection potentiates resistance to S-phase arrest-inducing chemotherapeutics by inhibiting CHK2 pathway in diffuse large B-cell lymphomaCell Death & Disease 2018; 9(2) doi: 10.1038/s41419-017-0097-1
47
Yu-Min Choi, So-Young Lee, Bum-Joon Kim. Naturally occurring hepatitis B virus reverse transcriptase mutations related to potential antiviral drug resistance and liver disease progressionWorld Journal of Gastroenterology 2018; 24(16): 1708-1724 doi: 10.3748/wjg.v24.i16.1708
48
Edina Amponsah-Dacosta, Ramokone L. Lebelo, J. Nare Rakgole, Rosemary J. Burnett, Selokela G. Selabe, M. Jeffrey Mphahlele. Evidence for a change in the epidemiology of hepatitis B virus infection after nearly two decades of universal hepatitis B vaccination in South AfricaJournal of Medical Virology 2014; 86(6): 918 doi: 10.1002/jmv.23910
49
Rebecca T. Horvat, Ryan Taylor. Manual of Clinical Microbiology2015; : 1841 doi: 10.1128/9781555817381.ch108
50
M. Sui, R. Wu, X. Hu, H. Zhang, J. Jiang, Y. Yang, J. Niu. Low prevalence of hepatitis B virus infection in patients with autoimmune diseases in a Chinese patient populationJournal of Viral Hepatitis 2014; 21(12): 925 doi: 10.1111/jvh.12302
51
Stephen G. Holt, Stephen Locarnini, Joe Sasadeusz. Hepatitis B related dilemmas in the renal unitNephrology 2021; 26(4): 287 doi: 10.1111/nep.13815
52
Tonny Ssekamatte, John Bosco Isunju, Paul Alex Kimoga Zirimala, Samuel Etajak, Saul Kamukama, Mathias Seviiri, Mary Nakafeero, Aisha Nalugya, Solomon Tsebeni Wafula, Edwinah Atusingwize, Justine. N. Bukenya, Richard K. Mugambe. A positive attitude among primary healthcare providers predicts better hepatitis B prevention practices: evidence from a cross-sectional survey in Wakiso district, Central UgandaHealth Psychology and Behavioral Medicine 2021; 9(1): 298 doi: 10.1080/21642850.2021.1904935
53
Neetu Rohit Kapoor, Vijay Kumar. Hepatitis B Virus: A Molecular PerspectiveProceedings of the National Academy of Sciences, India Section B: Biological Sciences 2012; 82(1): 31 doi: 10.1007/s40011-011-0003-z
54
Wei Pan, Zuoqiao Wu, Shuwen Wu, Deyin Guo, Xiaoyan Gong, Tien Po. Human Immunodeficiency Virus Coinfection with Hepatitis B Virus Leads to a Decrease in Extracellular and Intracellular Hepatitis B AntigenAIDS Research and Human Retroviruses 2015; 31(4): 461 doi: 10.1089/aid.2014.0291
55
Matthew B Carroll. The impact of biologic response modifiers on hepatitis B virus infectionExpert Opinion on Biological Therapy 2011; 11(4): 533 doi: 10.1517/14712598.2011.554810
56
DA-WU ZENG, YU-RUI LIU, JING DONG, YUE-YONG ZHU, YOU-BING LI, JING CHEN, QI ZHENG, JIA-JI JIANG. Serum HBsAg and HBeAg levels are associated with liver pathological stages in the immune clearance phase of hepatitis B virus chronic infectionMolecular Medicine Reports 2015; 11(5): 3465 doi: 10.3892/mmr.2015.3207
57
Hai-hua Sun, Dong-fang Zhou, Jun-ying Zhou. The role of DCs in the immunopathogenesis of chronic HBV infection and the methods of inducing DCs maturationJournal of Medical Virology 2016; 88(1): 13 doi: 10.1002/jmv.24306
58
M. Estée Török. Manson's Tropical Infectious Diseases2014; : 112 doi: 10.1016/B978-0-7020-5101-2.00014-5
59
Stefan Wirth. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition2016; : 681 doi: 10.1007/978-3-319-17169-2_60
60
Zhao H. Hou, Qiu J. Han, Cai Zhang, Zhi G. Tian, Jian Zhang. miR146a impairs the IFN-induced anti-HBV immune response by downregulating STAT1 in hepatocytesLiver International 2014; 34(1): 58 doi: 10.1111/liv.12244